These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8874043)

  • 1. Dopamine D2 receptor model explains binding affinity of neuroleptics: piquindone and its structure activity relationships.
    Teeter MM; Durand CJ
    Drug Des Discov; 1996 Apr; 13(3-4):49-62. PubMed ID: 8874043
    [No Abstract]   [Full Text] [Related]  

  • 2. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
    J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based identification of binding sites, native ligands and potential inhibitors for G-protein coupled receptors.
    Cavasotto CN; Orry AJ; Abagyan RA
    Proteins; 2003 May; 51(3):423-33. PubMed ID: 12696053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incorporation of butyrophenones and related compounds into a pharmacophore for dopamine D2 antagonists.
    Froimowitz M; Cody V
    Drug Des Discov; 1997 Aug; 15(2):63-81. PubMed ID: 9342550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting G-protein-coupled receptors: structure, function, and ligand interaction.
    Schwalbe H; Wess G
    Chembiochem; 2002 Oct; 3(10):915-9. PubMed ID: 12362356
    [No Abstract]   [Full Text] [Related]  

  • 6. Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors.
    Ballesteros JA; Shi L; Javitch JA
    Mol Pharmacol; 2001 Jul; 60(1):1-19. PubMed ID: 11408595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Picture story. Rhodopsin structure sees the light of day.
    Smith T
    Nat Struct Biol; 2000 Sep; 7(9):710. PubMed ID: 10966634
    [No Abstract]   [Full Text] [Related]  

  • 8. G-Protein coupled receptors: models, mutagenesis, and drug design.
    Bikker JA; Trumpp-Kallmeyer S; Humblet C
    J Med Chem; 1998 Jul; 41(16):2911-27. PubMed ID: 9685229
    [No Abstract]   [Full Text] [Related]  

  • 9. Homology modeling of the dopamine D2 receptor and its testing by docking of agonists and tricyclic antagonists.
    Teeter MM; Froimowitz M; Stec B; DuRand CJ
    J Med Chem; 1994 Sep; 37(18):2874-88. PubMed ID: 7915325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-cinnamyl-4-(2-methoxyphenyl)piperazines: synthesis, binding properties, and docking to dopamine (D(2)) and serotonin (5-HT(1A)) receptors.
    Penjisević J; Sukalović V; Andrić D; Kostić-Rajacić S; Soskić V; Roglić G
    Arch Pharm (Weinheim); 2007 Sep; 340(9):456-65. PubMed ID: 17763374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
    J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors.
    Millan MJ; Mannoury la Cour C; Novi F; Maggio R; Audinot V; Newman-Tancredi A; Cussac D; Pasteau V; Boutin JA; Dubuffet T; Lavielle G
    J Pharmacol Exp Ther; 2008 Feb; 324(2):587-99. PubMed ID: 18024789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of rhodopsin: a G-protein-coupled receptor.
    Stenkamp RE; Teller DC; Palczewski K
    Chembiochem; 2002 Oct; 3(10):963-7. PubMed ID: 12362360
    [No Abstract]   [Full Text] [Related]  

  • 14. New antipsychotic agents with serotonin and dopamine antagonist properties based on a pyrrolo[2,1-b][1,3]benzothiazepine structure.
    Campiani G; Nacci V; Bechelli S; Ciani SM; Garofalo A; Fiorini I; Wikström H; de Boer P; Liao Y; Tepper PG; Cagnotto A; Mennini T
    J Med Chem; 1998 Sep; 41(20):3763-72. PubMed ID: 9748351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, binding affinity, and molecular docking analysis of new benzofuranone derivatives as potential antipsychotics.
    Aranda R; Villalba K; Raviña E; Masaguer CF; Brea J; Areias F; Domínguez E; Selent J; López L; Sanz F; Pastor M; Loza MI
    J Med Chem; 2008 Oct; 51(19):6085-94. PubMed ID: 18783204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands.
    Ortega R; Raviña E; Masaguer CF; Areias F; Brea J; Loza MI; López L; Selent J; Pastor M; Sanz F
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1773-8. PubMed ID: 19217777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel atypical antipsychotic agents: rational design, an efficient palladium-catalyzed route, and pharmacological studies.
    Campiani G; Butini S; Fattorusso C; Trotta F; Gemma S; Catalanotti B; Nacci V; Fiorini I; Cagnotto A; Mereghetti I; Mennini T; Minetti P; Di Cesare MA; Stasi MA; Di Serio S; Ghirardi O; Tinti O; Carminati P
    J Med Chem; 2005 Mar; 48(6):1705-8. PubMed ID: 15771414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SH3 binding domains in the dopamine D4 receptor.
    Oldenhof J; Vickery R; Anafi M; Oak J; Ray A; Schoots O; Pawson T; von Zastrow M; Van Tol HH
    Biochemistry; 1998 Nov; 37(45):15726-36. PubMed ID: 9843378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrahydroisoquinolines as dopaminergic ligands: 1-Butyl-7-chloro-6-hydroxy-tetrahydroisoquinoline, a new compound with antidepressant-like activity in mice.
    Berenguer I; El Aouad N; Andujar S; Romero V; Suvire F; Freret T; Bermejo A; Ivorra MD; Enriz RD; Boulouard M; Cabedo N; Cortes D
    Bioorg Med Chem; 2009 Jul; 17(14):4968-80. PubMed ID: 19540762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
    J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.